BAS
ARNA

Brown Advisory Securities’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Brown Advisory Securities’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,000
Closed -$84K – 321
2014
Q3 		$84K Buy
+2,000
New +$89.3K 0.03% 263
2014
Q2 		– Sell
-2,000
Closed -$126K – 320
2014
Q1 		$126K Buy
+2,000
New +$133K 0.05% 253
2013
Q4 		– Sell
-2,000
Closed -$105K – 299
2013
Q3 		$105K Hold
2,000
– – 0.05% 244
2013
Q2 		$154K Buy
+2,000
New +$163K 0.07% 212

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Advisory Securities's ARNA Position: Q4 2014 in Review

Brown Advisory Securities sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2014, closing a stake of 2,000 shares — an estimated $84K sold.

Brown Advisory Securities first reported a position in ARNA in Q2 2013 and held it in 4 quarters. The position peaked at $154K in Q2 2013. 129 funds tracked by Wall St. Rank hold ARNA as of Q4 2014.

  • Brown Advisory Securities reported no remaining Arena Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Brown Advisory Securities sold 2,000 Arena Pharmaceuticals Inc shares in Q4 2014, an estimated $84K.
  • Brown Advisory Securities first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Brown Advisory Securities's Arena Pharmaceuticals Inc position peaked at $154K in Q2 2013.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2014.

Based on Brown Advisory Securities's 13F filing for Q4 2014, filed 9 Feb 2015.